COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

Authors :: Francesca Palandri
Francesco Albano
Alessandra Iurlo
Francesco Passamonti
Sergio Siragusa
Guido Finazzi
Marco Vignetti
Paola Fazi
Stefano Soddu
Alessandro M. Vannucchi
Valerio De Stefano
Massimo Breccia
Bruno Martino
Alfonso Piciocchi
Breccia M.
Piciocchi A.
De Stefano V.
Finazzi G.
Iurlo A.
Fazi P.
Soddu S.
Martino B.
Palandri F.
Siragusa S.
Albano F.
Passamonti F.
Vignetti M.
Vannucchi A.M.
Source :: Leukemia
Publication Year :: 2020
Publisher :: Springer Science and Business Media LLC, 2020.

Subjects :: 2019-20 coronavirus outbreak
Pediatrics
medicine.medical_specialty
Cancer Research
Coronavirus disease 2019 (COVID-19)
Epidemiology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pneumonia, Viral
Philadelphia chromosome
Severity of Illness Index
Myeloproliferative disease
Betacoronavirus
Myeloproliferative Disorders
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Correspondence
Nitriles
medicine
Humans
Philadelphia Chromosome
Betacoronavirus, COVID-19, Coronavirus Infections, Cross-Sectional Studies, Disease Progression, Humans, Italy, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Philadelphia Chromosome, Pneumonia, Viral, Pyrazoles, SARS-CoV-2, Severity of Illness Index, Survival Analysis, Pandemics
Pandemics
Philadelphia negative
business.industry
SARS-CoV-2
Disease progression
COVID-19
Hematology
medicine.disease
Survival Analysis
Cross-Sectional Studies
Pyrimidines
Italy
Oncology
Disease Progression
Pyrazoles
business
Coronavirus Infections

Full Text Access

Tools